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Abstract To improve (pre)malignant lesion identification in
Barrett’s esophagus (BE), recent research focuses on new de-
velopments in fluorescence imaging and spectroscopy to en-
hance tissue contrast. Our aim was to validate the chorioallan-
toic membrane (CAM) model as a preclinical tool to study the
fluorescence characteristics such as autofluorescence and ex-
ogenously induced fluorescence of human Barrett’s tissue.
Therefore, esophageal biopsy specimens from Barrett’s pa-
tients were freshly grafted onto the CAM of fertilized hen’s
eggs to simulate the in vivo situation. The BE biopsy speci-
mens stayed between 1 and 9 days on the CAM to study the
persistence of vitality. Fluorescence spectroscopy was per-
formed using six excitation wavelengths (369, 395, 400,
405, 410, 416 nm). Obtained autofluorescence spectra were
compared with in vivo spectra of an earlier study. Exogenous
administration of 5-aminolevulinic-acid to the biopsy speci-
mens was followed by fluorescence spectroscopy at several
time points. Afterwards, the biopsy specimens were harvested
and histologically evaluated. In total, 128 biopsy specimens
obtained from 34 patients were grafted on the CAM. Biopsy
specimens which stayed on average 1.7 days on the CAM
were still vital. Autofluorescence spectra of the specimens
correlated well with in vivo spectra. Administered 5-
aminolevulinic-acid to the biopsy specimens showed conver-
sion into protoporphyrin-IX. In conclusion, we showed that
grafting freshly collected human BE biopsy specimens on the
CAM is feasible. Our results suggest that the CAM model
might be used to study the fluorescence behavior of human
tissue specimens. Therefore, the CAM model might be a pre-
clinical research tool for new photosensitizers.
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Introduction
Patients with Barrett’s esophagus (BE) are recommended to
undergo regular surveillance endoscopy to detect malignant
lesions at an early stage. Esophageal adenocarcinoma de-
velops from premalignant stages of dysplasia, which can be
histologically graded. These precursor lesions are amenable to
curative and minimally invasive endoscopy therapy, due to the
low risk of lymph node metastasis. With a low morbidity and
mortality compared to esophagectomy and an excellent 5-year
survival rate, the timely detection of early dysplasia is of great
clinical importance [1–4].
Early changes in tissue during the progression into malig-
nancy occur at a (sub)cellular level and consist of morpholog-
ical and chemical changes which cannot be seen during stan-
dard endoscopic diagnostic procedures such as white light
endoscopy. Recent developments to improve real-time diag-
nostics focus on imaging such as high-resolution white light
endoscopy (HR-WLE), confocal endomicroscopy, narrow-
band imaging (NBI), and autofluorescence imaging (AFI);
the latest suffers from a high false-positive rate [5–11].
Although a lot of effort has been put in these new
* Jasmin A. Holz
j.a.holz@amc.uva.nl
1 Department of Biomedical Engineering and Physics, Academic
Medical Center, Meibergdreef 9,
1105AZ Amsterdam, The Netherlands
2 Department of Gastroenterology and Hepatology, AcademicMedical
Center, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands
3 Department of Pathology, Academic Medical Center, Meibergdreef
9, 1105AZ Amsterdam, The Netherlands
Lasers Med Sci (2016) 31:137–144
DOI 10.1007/s10103-015-1839-x
technologies, none are currently able to clearly discriminate in
real time healthy from premalignant tissue during standard
surveillance endoscopy. But these (sub)cellular changes in
premalignant tissue do affect the optical absorption and scat-
tering properties of the tissue which might be detected by
fluorescence spectroscopy [12–15]. In addition, photosensi-
tizers, such as 5-aminolaevulinic acid (5-ALA)may be admin-
istered to enhance the tissue contrast [16, 17]. Administration
of 5-ALA leads to the formation of the fluorescent
protoporphyrin-IX (PpIX). Metabolic differences between tis-
sue types cause concentration variations. At specific times, the
concentration of PpIX inside the (pre)malignant tissue [13] is
higher compared to normal tissue levels, which shows as in-
creased fluorescence and is therefore often used to improve
the discrimination between dysplastic and non-dysplastic ep-
ithelium. This so-called photodiagnosis provides real-time in-
formation that can be used to red flag areas of interest during
medical procedures for the detection of (early) cancer.
For developing new photosensitizers and the characteriza-
tion of current sensitizers, usually cell experiments and/or an-
imal experiments are used. The physiology and overall drug-
cell interactions are far from the in vivo situation. Animal
experiments are expensive and cumbersome. A model which
is very suitable for studying the localization of the particles
and the treatment efficacy is the chick embryo chorioallantoic
membrane (CAM) model which uses the well-vascularized
chorioallantoic membrane of fertilized chicken eggs on which
tumors can be implanted [18–20]. After implantation, angio-
genesis allows the tumor to grow. Because of the easy acces-
sibility of the systemic and tumor circulation, it is possible to
illuminate the CAM and study the fluorescence yield and, if
applicable, treatment effect. The CAM model is the bridge
between the preliminary cell experiments and the in vivo
tumor-bearing animal models. To mimic the in vivo situation
even better, we grafted freshly excised tissue biopsies directly
onto the CAM, thereby maintaining the heterogeneity and
tumor architecture, which are lost in homogenous cultures of
tumor tissue.
Our aim was to validate the CAM model as a preclinical
tool to study the fluorescence characteristics of human
Barrett’s tissue and therefore the potential use to test future
photosensitizers. First, we studied the vitality of freshly hu-
man BE tissue biopsies grafted onto the CAM by examining
the hematoxylin and eosin (H&E)-stained slices of the har-
vested biopsies. Furthermore, the autofluorescence spectra ob-
tained from the grafted tissue were compared with in vivo
autofluorescence spectra, and the well-known 5-ALAwas top-
ically administered to test the CAM model for the usage of
photosensitizer. As light source, a multi-wavelength spectros-
copy system consisting of several discrete excitation wave-
lengths around the 405-nm Soret absorption peak of PpIX
was used. This setting was chosen to find the optimal excita-
tion wavelength of PpIX in Barrett’s tissue to optimize new




A custom-made spectroscopy system was developed (2M
Engineering Ltd., Veldhoven, the Netherlands) for endoscopic
in vivo measurements comprising a LED with 369 nm (FWHM
of 16 nm) and laser diodes at 395, 400, 405, 410, and 416 nm
[15]. The system was connected to an optical fiber probe which
delivered the excitation light to the tissue and the fluorescence
light back to the connected spectrometer USB4000 (Ocean
Optics Inc., Dunedin, Florida, USA) and laptop for spectral re-
cording. The distal fiber probe tip had an outer diameter of 2mm
and an inner functional diameter of 0.82 mmwhich consisted of
a bundle of 30 fibers, thus 15 illumination and 15 collection
fibers. Proximal, the 15 collection fibers were aligned to the
200-μm entrance slit of the spectrometer. The biopsy specimens
were placed perpendicular under the tip of the probe, thus mim-
icking the in vivo endoscopic setting.
CAM model
Fertilized hen’s eggs obtained from Drost Loosdrecht BV
(Loosdrecht, The Netherlands) were incubated for 3 days in
a Polyhatch incubator (Brinsea Products Inc., Titusville,
Florida, USA) at 38–39 °C, 60–80 % humidity, rotating every
1 h. At embryonic day 3, a volume of 2–3 mL albumen was
removed from the egg using a 21-G needle injected into the air
pocket of the egg in order to lower the level of the CAM inside
the egg. Awindow of approximately 1.5 cm2 was cut into the
outer shell on top of the egg in order to gain access to the
CAM, using blades and scissors. After checking if the embryo
was alive, the window was covered with transparent plastic
and the egg was placed in a hatcher (Brinsea Products Inc.,
Titusville, Florida, USA) at 37.5 °C, 50–70 % humidity.
When outside the hatcher, the eggs were handled on a heating
plate at 37 °C in a laminar flow hood.
Patient selection and biopsy grafting onto the CAM
Patients scheduled for surveillance endoscopy of non-dysplastic
BE (NDBE) or work-up or treatment of early Barrett’s neoplasia
at the department of Gastroenterology and Hepatology of the
Academic Medical Center (AMC) Amsterdam were included.
The Medical Ethics Committee of the AMC Amsterdam ap-
proved the study and all included patients were informed and
signed a consent form. Biopsies of lesions suspicious for dyspla-
sia within the BE and of endoscopically unsuspicious areas of
BE were obtained from 34 patients (two to four biopsies per
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patient). Immediately after the biopsies were obtained, they were
transferred into preheated 37.5 °C transport medium (DMEM,
FCS, PenStrep, L.Glut, Fungizone).
At embryonic day 6 of incubation, the egg was placed in
the laminar flow hood on a heating plate at 37 °C. The plastic
cover was lifted from the egg, and the CAMwas cleaned at the
location for tissue grafting with ethanol-treated lens paper.
The freshly obtained biopsy specimens were subsequently
spread on a gloved finger and with the help of two pairs of
tweezers carefully spread and placed on the CAM.One biopsy
specimen was grafted per egg. The transparent cover was
closed, and the egg put back in the hatcher.
Spectroscopy procedure
The egg was placed in the laminar flow hood and positioned
under the spectroscopy set-up. All measurements were per-
formed in a dark room. The optical fiber probe was placed
about 1 mm above the biopsy specimen, followed by sequen-
tial illumination by all light sources and recording of the fluo-
rescence spectra, including a dark measurement (all light
sources off). Subsequently, spectra were recorded adjacent to
the biopsy specimen and on the CAM only which was approx-
imately 2 cm from the biopsy specimen. Each saved spectrum
was composed of the average of three measurements per site.
For the fluorescence spectroscopy measurements with 5-ALA
administration, 20 μL of 10 mM 5-ALA (Sigma Chemical
Co.) dissolved in 0.9 % NaCl solution was topically adminis-
tered to each biopsy specimen. Fluorescence spectroscopy
was performed at several time points between 0 h before and
23 h after 5-ALA administration. After the last measurement,
the biopsy specimens were removed from the CAM and fixed
in formalin, embedded in paraffin, and cut and stained with
hematoxylin and eosin (H&E). Histopathological assessment
of the biopsy specimens was performed by an expert GI pa-
thologist. Biopsies which were considered vital were classified
into two groups, suspicious for dysplasia called Bdysplastic^
and not suspicious for dysplasia called Bnon-dysplastic.^
Finally, the embryo was terminated by high-dose isoflurane.
Data analysis
The obtained autofluorescence spectra of the biopsy specimens
on theCAMwere analyzed in the sameway as the in vivo spectra
which we obtained in an earlier study [15]. Pearson’s correlation
coefficient r and the coefficient of determination r2 were calcu-
lated to assess the relationship between the autofluorescence
spectra from the biopsy specimens and the in vivo spectra.
From all emission spectra, obtained from the biopsy spec-
imens used for 5-ALA measurements, the corresponding dark
spectrum was subtracted. The intensity ratio I636/I600 of the
PpIX fluorescence peak at 636 nm to a reference emission
wavelength at 600 nm was calculated for each spectrum.
This corrects for variations in applied laser power, probe po-
sitioning, and system noise. The mean intensity ratios, the
standard deviation (SD), and the standard error of the mean
(SEM)were calculated. The statistical relevance of differences
in intensity ratios per excitation wavelength and time point
was determined by repeated measures one-way ANOVAwith
subsequent Bonferroni correction using Prism 5 (GraphPad
Software Inc., La Jolla, California, USA). The results of
Bonferroni’s multiple comparison test were considered signif-
icant when the p value was <0.05.
Imaging
Images were obtained from the biopsy specimens on the CAM
using a Dino-Lite digital microscope in cross-polarized white
light imaging mode (AM413ZT, AnMo Electronics Corp.,
Hsinchu, Taiwan) before and after 5-ALA administration.
Fluorescence imaging was performed to obtain an overview
of the PpIX distribution on the biopsy specimens and CAM.
Fluorescence images were obtained at blue light illumination
ranging from 400 to 430 nm (Crime-lite® 2, Foster+Freeman
Ltd., Evesham, UK). A digital camera (Nikon D40X) with a
long pass filter (GG455, Foster+Freeman) in front of the lens
was used to allow only the detection of emitted fluorescence at
longer wavelengths than 435 nm.
Fig. 1 a Image of Barrett’s esophageal biopsy specimen on the CAM; b
fluorescence spectroscopy performed on a biopsy specimen; cwhite light
microscope image with ×10 magnification of H&E-stained slice of a
human biopsy specimen which stayed 1 day on the CAM
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Results
Biopsy assessment and autofluorescence spectra
evaluation
In total, 63 biopsy specimens, obtained from 25 Barrett’s pa-
tients, stayed between 1 and 9 days on the CAM. Twenty-six
biopsy specimens showed necrosis and were not classified his-
topathologically. Fourteen other histology slices did not contain
enough tissue for an assessment. From the remaining 23 biopsy
specimens, 9 were classified as not suspicious for dysplasia
(non-dysplastic) thus squamous or non-dysplastic Barrett’s
esophagus (NDBE) and 14 as suspicious for dysplasia (dys-
plastic). The 23 biopsies which could be classified stayed on
average 1.7 days on the CAM. Figure 1a shows an image of a
Barrett’s biopsy specimen on the CAM.
Autofluorescence spectroscopy was performed, see
Fig. 1b, on 8 of the 9 non-dysplastic biopsies and on 10 of
the 14 dysplastic-classified biopsies. Pearson’s correlation co-
efficient r and the coefficient of determination r2 (Table 1)
were calculated to correlate ex vivo and in vivo averaged
autofluorescence spectra obtained with the same system
[15]. The ex vivo dysplastic autofluorescence spectra correlat-
ed well with the in vivo (HGIN/CA) spectra with an r2 value
of around 0.99. The non-dysplastic spectra correlated less with
the in vivo (IM) spectra having an r2 value of around 0.97.
Figure 2 shows the averaged autofluorescence spectra at 395-
nm excitation from in vivo (HGIN/CA) and ex vivo
(dysplastic) esophageal tissue with an r2 value of 0.987.
Figure 1c shows the H&E-stained slice of a human biopsy
specimen which stayed 1 day on the CAM. In the upper part,
the CAM cells are seen, and in the lower part, the human
tissue seemed to be vital and attached to the CAM tissue.
5-ALA-induced fluorescence spectra evaluation
A total of 65 biopsies, obtained from 20Barrett’s patients, stayed
between 2 and 4 days on the CAMandwere then examinedwith
5-ALA-induced spectroscopy. Histopathological evaluation of
the harvested biopsies was not possible for 25 biopsy specimens
due to intensive necrosis and 10 more slices contained not
enough tissue for an assessment. From the remaining 30 biopsy
specimens, 12 were classified as not suspicious for dysplasia
(non-dysplastic) thus squamous or NDBE and 18 as suspicious
for dysplasia (dysplastic). Three spectra of non-dysplastic biopsy
specimens were excluded from the analysis due to measurement
issues. Table 2 gives an overview of the spectra included for the
analysis at all six excitation wavelengths obtained from 12
patients.
Figure 3 shows typical emission spectra with subtracted
dark spectrum before normalization at all six excitation wave-
lengths, 6 h after 5-ALA administration, of a biopsy specimen
(dysplastic) on the CAM (a), the CAM adjacent to the biopsy
specimen (b), and the CAM only (d). Fluorescence spectra of
the biopsy specimens on the CAM showed PpIX fluorescence
peaks at 636 nm. Maximum autofluorescence was observed
Fig. 2 Averaged
autofluorescence spectra at 395-
nm excitation from in vivo
(HGIN/CA) and ex vivo
(dysplastic) esophageal tissue
Table 1 Coefficient of determination r2 of averaged ex vivo versus in
vivo autofluorescence spectra for non-dysplastic and dysplastic
esophageal tissue
Non-dysplastic
ex vivo vs. in vivo
Dysplastic ex
vivo vs. in vivo
369 nm 0.977 0.976
395 nm 0.961 0.987
405 nm 0.961 0.991
410 nm 0.969 0.991
416 nm 0.968 0.991
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around 500 nm. In contrast, the emission spectra adjacent to
the biopsy specimens showed negligible autofluorescence and
a clear PpIX fluorescence profile. The main difference be-
tween the biopsy specimens and the adjacent fluorescence
was that the CAM did not show porphyrin fluorescence at
the 620- and 680-nm emissions. Fluorescence spectra of the
CAM only revealed slightly less autofluorescence compared
to the biopsy specimen and negligible PpIX fluorescence
compared to the biopsy specimens and the surrounding CAM.
The PpIX intensity ratios I636/I600 did not differ significant-
ly between dysplastic and non-dysplastic tissue. Therefore,
and due to the low amount of biopsy specimens classified as
non-dysplastic, we decided to analyze all biopsy specimens
(Table 2) per time point and excitation wavelength in one
group, to which we refer further as BE tissue.
The intensity ratios I636/I600 of BE tissue showed increased
PpIX fluorescence with increasing excitation wavelength and
time point (Fig. 4a). Bonferroni’s multiple comparison tests of
all pairs of time points showed a significant increase in the
intensity ratios at 0 vs. 6 h, 0 vs. 23 h, 1.5 vs. 23 h, and 4.5
vs. 23 h at all excitation wavelengths. Intensity ratios at 369-nm
excitation were significantly lower compared to 405-, 410-, and
416-nm excitation at all time points. The intensity ratios at 410-
and 416-nm excitation at 4.5 h were significantly higher com-
pared to 0 h. At 4.5 h after 5-ALA administration, the PpIX
intensity ratios at 416-nm excitation were significantly higher
compared to all other excitation wavelengths except 410 nm.
Each measurement at 4.5 h after 5-ALA administration
separately showed that in 96% (23/24) of the cases, the highest
PpIX fluorescence intensity ratios were obtained at 410-nm
(63 %) and 416-nm (33 %) excitations. The lowest intensity
ratios were obtained at 369-nm excitation in 96 % (23/24) of
the cases. The intensity ratios at 410-nm excitation were 2.3
times higher (SD: ±0.8) compared to 369-nm excitation.
The intensity ratios I636/I600 on the CAM adjacent to the BE
tissue (Fig. 4b) tend to increase faster and became higher com-
pared to the BE tissue. There was a significant increase of the
intensity ratios on the CAM adjacent to the BE tissue between
time point 0 vs. 1.5 h, 0 vs. 4.5 h, 0 vs. 6 h, and a significant
decrease at time points 4.5 vs. 23 h and 6 vs. 23 h at all exci-
tation wavelengths except 369 nm. At 23 h after 5-ALA ad-
ministration, the PpIX fluorescence was back at baseline level
(t=0). The PpIX fluorescence on the CAM only (Fig. 4c) in-
creased significantly after 6 h, but those intensity ratios were
negligible (five to seven times lower) compared to the intensity
ratios obtained from the BE tissue or adjacent to it.
Fluorescence imaging was performed to obtain an overview
of the PpIX distribution on the BE tissue and CAM.
Fluorescence images (Fig. 5) taken several hours after 5-ALA
administration showed first a strong red fluorescence surround-
ing the BE tissue and with increasing time increasing fluores-
cence of the BE tissue and decreasing fluorescence of the sur-
rounding CAM.
Discussion
The evaluation of the CAM model showed that biopsy speci-
mens were still vital after 1.7 days on the CAM, on average. The
lower intensities of the ex vivo autofluorescence spectra around
500 nm might be caused by the different measurement proce-
dures; in vivo, the probe was in contact with the tissue site under
investigation, whereas ex-vivo, the probe did not touch the bi-
opsy specimen. Whereas, the higher intensities in the rest of the
ex vivo autofluorescence spectra might be caused by lower
blood absorption compared to the in vivo situation. Despite these
deviations, the overall correlation of the ex vivo with the in vivo
autofluorescence spectra showed good resemblance.
Fig. 3 Typical emission spectra with subtracted dark spectrum at all six excitation wavelengths, 6 h after 5-ALA administration, of a biopsy specimen
(dysplastic) on the CAM (a), the CAM adjacent to the biopsy specimen (b), and the CAM only (c)
Table 2 Number of analyzed human biopsy specimens on the CAM
per time point and their histological classification





0 h 9 18 27
1.5 h 9 18 27
4.5 h 8 16 24
6 h 6 11 17
23 h 2 7 9
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Previous research using the CAM model in combination
with 5-ALA focused on tumor specimens and cell lines
[21–24]. The observed conversion into PpIX in our study
suggests the existence of a functional metabolism within the
BE tissue. As expected, the lowest PpIX intensities were in-
duced with the shortest wavelength, 369 nm, which is about
30 nm below the Soret band of PpIX. The highest PpIX in-
tensities were induced at 410- and 416-nm excitations without
a significant difference between them.
In our study, BE tissue showed increased PpIX fluores-
cence with increasing time, which is in agreement with known
in vivo observations. The BE tissue showed no significantly
reduced PpIX fluorescence after 23 h, which indicates a
slower PpIX clearance compared to in vivo observations
[25–28]. This increased clearance time might be caused by
the topical bolus administration of ALA. The excessive
ALA is not removed, and therefore, the tissue exposure is
expected to be longer compared to in vivo conditions.
Furthermore, the ALA diffusion into the tissue and redistribu-
tion within the egg might be prolonged in the CAM model.
The in vivo kinetics were already studied [25–28]; therefore,
we focused on studying the CAM model as a preclinical ap-
proach for fluorescence diagnostics with special interest in
photosensitizer. This preclinical model benefits from no pa-
tient hazard, and it is a more physiological approach then
studying cells in vitro. The fluorescence of the CAM adjacent
to the BE tissue showed a faster increase and decrease of
induced PpIX, whereas the PpIX fluorescence and autofluo-
rescence of the CAM only showed negligible intensities.
Fluorescence images showed that the high PpIX fluorescence
adjacent to the biopsy specimens was due to the topical appli-
cation of 5-ALA surrounding the biopsy specimens.
Although the CAM model was applicable for our research
purpose, the spectroscopymeasurements had several limitations.
The spectroscopy set-up used a mounted probe, to ensure stable
measurements. However, due to movements of the embryo and
therefore repositioning of the BE tissue under the probe, equal
distances and angles of the measurements cannot be assured and
sometimes measurements needed to be repeated. The histologi-
cal classification showed that around 40%of the grafted biopsies
did not stay vital on the CAM and therefore needed to be ex-
cluded from the analysis. This necessitates the usage of an in-
creased amount of biopsies or an optimized protocol, for exam-
ple, by leaving the biopsy specimens a maximum of 2 days on
the CAM or daily administration of growth factors and/or medi-
um to the tissue on the CAM which may prolong tissue vitality.
Differentiation between BE tissue and the CAM was pos-
sible, due to the differences in spectral shape, 5-ALA kinetics,
and the wavelength-dependent intensity ratios. The main dif-
ference between BE tissue and the CAM spectra was that the
CAM did not show porphyrin fluorescence at the 620- and
680-nm emissions (Fig. 3). This fluorescence might be caused
by the formation of water-soluble porphyrins [29].
In conclusion, we showed that grafting freshly collected
human BE biopsy specimens on the CAM is feasible. Our
results suggest that the CAM model might be used to study
fluorescence diagnostics such as autofluorescence and in-
duced fluorescence behavior of human biopsy specimens on
the CAM as a preclinical research tool. Further preclinical
research is recommended, with an increased amount of biop-
sies from non-dysplastic and dysplastic BE tissue, to assess
the potential in tissue discrimination. Furthermore, with the
CAM model keeping human tissue vital for a few days, the
responses to new photosensitizer might be evaluated. Besides
that, our current fluorescence spectroscopy system can be
modified by adding a white light source for additional
Fig. 5 Fluorescence images of BE tissue on the CAM at 3, 6, and 23 h
after 5-ALA administration
Fig. 4 Mean PpIX intensity ratios I636/I600 with standard error of the mean at 0, 1.5, 4.5, 6, and 23 h after 5-ALA administration obtained from the BE
tissue on the CAM (a), the CAM adjacent to the BE tissue (b), and the CAM only (c)
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reflectance spectroscopy which had shown its potential in en-
doscopic detection of dysplasia [30–32].
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